| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9154514 | American Heart Journal | 2005 | 7 Pages |
Abstract
Carvedilol therapy is associated with a sustained decline in BNP and NANP levels. Serial BNP levels can provide some guidance regarding probability of LVEF improvement, but the relationship is not strong enough for BNP levels to supplant measurement of LVEF.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Robert P. MD, Lyle J. MD, Diane MS, Soundos K. MD, Susan M. LPN, Thomas P. MD, Richard D. MD, Richard J. MD, Farouk MD, Denise MD, Kent R. PhD, John C. MD,